Related Experiment Video
Updated: May 26, 2026

04:35
Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment
Published on: December 27, 2024
Sublingual reactive histiocytosis in a dog
Luisa Cornegliani1, Margherita Gracis, Silvia Ferro
1Clinica Veterinaria San Siro, Milano, Italy. lcornegliani@libero.it
Journal of Veterinary Dentistry
|December 31, 2011
Summary
A rare sublingual mass in a Miniature Pinscher was diagnosed as reactive histiocytosis, a disorder of antigen-presenting cells. Treatment with tetracycline and niacinamide led to complete resolution and no recurrence after two years.
Area of Science:
- Veterinary Pathology
- Canine Dermatology
- Immunohistochemistry
Background:
- Lingual lesions in dogs are uncommon, often linked to neoplasms, trauma, or infections.
- Reactive histiocytosis is a poorly understood disorder involving activated dendritic cells, lymphocytes, and neutrophils, with a characteristic angiocentric pattern.
- This condition can exhibit fluctuating clinical behavior, with potential for regression or systemic involvement.
Observation:
- A case report details an unusual sublingual presentation of reactive histiocytosis in a Miniature Pinscher.
- Diagnosis was confirmed through clinical and histopathological exclusion, identification of the characteristic microscopic pattern, and immunocytochemistry.
- Immunohistochemistry revealed histiocytic cells positive for vimentin, CD18, CD11c, and CD1c, supporting a dendritic cell origin.
Findings:
- The sublingual mass in the dog was diagnosed as reactive histiocytosis.
- Immunohistochemical markers confirmed the dendritic cell nature of the proliferating cells.
- The anti-Bacillus Calmette and Guerin (BCG) stain was negative, ruling out specific etiological agents.
Implications:
- This case highlights an unusual sublingual manifestation of reactive histiocytosis in dogs.
- Successful treatment with oral tetracycline and niacinamide was observed over an 8-month period.
- The absence of recurrence two years post-treatment suggests a favorable prognosis with this therapeutic approach for canine reactive histiocytosis.
